1. Home
  2. SHPH vs NAOV Comparison

SHPH vs NAOV Comparison

Compare SHPH & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHPH
  • NAOV
  • Stock Information
  • Founded
  • SHPH 2012
  • NAOV 2003
  • Country
  • SHPH United States
  • NAOV United States
  • Employees
  • SHPH N/A
  • NAOV N/A
  • Industry
  • SHPH Biotechnology: Pharmaceutical Preparations
  • NAOV Industrial Specialties
  • Sector
  • SHPH Health Care
  • NAOV Health Care
  • Exchange
  • SHPH Nasdaq
  • NAOV Nasdaq
  • Market Cap
  • SHPH 2.3M
  • NAOV 2.4M
  • IPO Year
  • SHPH 2022
  • NAOV N/A
  • Fundamental
  • Price
  • SHPH $0.18
  • NAOV $0.90
  • Analyst Decision
  • SHPH
  • NAOV
  • Analyst Count
  • SHPH 0
  • NAOV 0
  • Target Price
  • SHPH N/A
  • NAOV N/A
  • AVG Volume (30 Days)
  • SHPH 12.3M
  • NAOV 4.9M
  • Earning Date
  • SHPH 05-08-2025
  • NAOV 05-20-2025
  • Dividend Yield
  • SHPH N/A
  • NAOV N/A
  • EPS Growth
  • SHPH N/A
  • NAOV N/A
  • EPS
  • SHPH N/A
  • NAOV N/A
  • Revenue
  • SHPH N/A
  • NAOV $2,662,000.00
  • Revenue This Year
  • SHPH N/A
  • NAOV N/A
  • Revenue Next Year
  • SHPH N/A
  • NAOV N/A
  • P/E Ratio
  • SHPH N/A
  • NAOV N/A
  • Revenue Growth
  • SHPH N/A
  • NAOV N/A
  • 52 Week Low
  • SHPH $0.16
  • NAOV $0.67
  • 52 Week High
  • SHPH $4.30
  • NAOV $16.25
  • Technical
  • Relative Strength Index (RSI)
  • SHPH 38.08
  • NAOV 30.09
  • Support Level
  • SHPH $0.16
  • NAOV $0.67
  • Resistance Level
  • SHPH $0.19
  • NAOV $1.08
  • Average True Range (ATR)
  • SHPH 0.02
  • NAOV 0.19
  • MACD
  • SHPH 0.01
  • NAOV 0.05
  • Stochastic Oscillator
  • SHPH 38.80
  • NAOV 25.80

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

Share on Social Networks: